Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Antibodies
pSivida signs tech evaluation deal for Tethadur protein/antibody delivery system
Antibodies : 01 August, 2012
pSivida signs a funded technology evaluation agreement with a leading global biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology in the field of ophthalmology.
 
Life Technologies signs collaborative antibody deal with Structural Genomics Consortium
Antibodies : 23 July, 2012
Life Technologies signs a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.
 
Ventana receives 510(k) clearance for H. pylori antibody
Antibodies : 06 October, 2011
The VENTANA anti-Helicobacter pylori (SP48) Rabbit Monoclonal Primary Antibody (H. pylori) is the first H. pylori antibody to receive 510(k) clearance from the Food and Drug Administration (FDA).
 
NanoBio secures novel antigen source for intranasal RSV vaccine
Antibodies : 04 August, 2011
NanoBio signs a licensing agreement with the National Institutes of Health (NIH) that represents a step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.
 
NanoBio signs an antigen licensing deal with the University of Michigan
Antibodies : 21 April, 2011
NanoBio signs a licensing agreement with the University of Michigan that provides NanoBio with rights to an antigen that has been shown to prevent urinary tract infections (UTIs) following intranasal vaccination.
 
Boehringer Ingelheim partners Micromet to develop multiple myeloma antibody
Antibodies : 11 May, 2010
Boehringer Ingelheim and Micromet enter into a collaboration agreement for the research, development and commercialisation of a new BiTE antibody for the treatment of multiple myeloma.
 
New set of monoclonal antibodies to T gondii is offered by ViroStat
Antibodies : 19 January, 2010
ViroStat releases a new set of monoclonal antibodies to T gondii with four different antigen specificities being made available including SAG1 and MIC 3.
 
Sigma-Aldrich boosts antibody portfolio to more than 6000
Antibodies : 24 June, 2009
Sigma-Aldrich releases more than 2300 antibody additions to its Prestige Antibodies powered by Atlas Antibodies product range to bring the total number of validated antibodies to more than 6100.
 
Sigma-Aldrich introduces esiRNA tool for RNAi screening requirements
Antibodies : 29 April, 2009
Sigma-Aldrich is releasing its MISSION esiRNA tool, a pool of gene-specific siRNA that provides a novel approach to RNAi screening in mammalian cells.
 
Sigma-Aldrich adds 2,000 antibodies to its Prestige portfolio
Antibodies : 20 August, 2008
Sigma-Aldrich has added more than 2,000 antibodies to its range of Prestige Antibodies.
 
Antibody engineering company opens UK research facility
Antibodies : 13 March, 2008
f-star, an antibody engineering company developing novel antibodies and antibody fragments, is to open a research facility in Cambridge, UK.
 
Bionomics receives milestone payment from Genmab for protein successes
Antibodies : 20 February, 2008
Bionomics has successfully completed the pre-clinical testing on the first of eight proteins licensed to $2.6 billion Danish antibody company Genmab, triggering a $1 million milestone payment.
 
Sigma-Aldrich forms exclusive distribution partnership with Atlas Antibodies
Antibodies : 15 February, 2008
An exclusive partnership has formed between Sigma-Aldrich and Atlas Antibodies to distribute Prestige Antibodies - developed by the Human Proteome Resource - to the proteomics and cell biology research communities.
 
Sigma-Aldrich launches new antibodies catalogue featuring 4,000 products
Antibodies : 28 November, 2007
Sigma-Aldrich has announced the new 2007-2008 Sigma Antibodies Catalog, a 320-page Sigma Antibodies product catalogue that contains information on more than 4,000 antibodies from a single source.
 
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo